These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29549312)

  • 41. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis.
    Orosa B; García S; Conde C
    Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Production of bioactive lysophosphatidic acid by lysophospholipase D in hen egg white.
    Morishige J; Touchika K; Tanaka T; Satouchi K; Fukuzawa K; Tokumura A
    Biochim Biophys Acta; 2007 Apr; 1771(4):491-9. PubMed ID: 17321793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased production of bioactive lysophosphatidic acid by serum lysophospholipase D in human pregnancy.
    Tokumura A; Kanaya Y; Miyake M; Yamano S; Irahara M; Fukuzawa K
    Biol Reprod; 2002 Nov; 67(5):1386-92. PubMed ID: 12390867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and pharmacological characterization of a novel inhibitor of autotaxin in rodent models of joint pain.
    Thirunavukkarasu K; Swearingen CA; Oskins JL; Lin C; Bui HH; Jones SB; Pfeifer LA; Norman BH; Mitchell PG; Chambers MG
    Osteoarthritis Cartilage; 2017 Jun; 25(6):935-942. PubMed ID: 27638130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of serum ATX and LPA as potential diagnostic biomarkers in patients with pancreatic cancer.
    Chen J; Li H; Xu W; Guo X
    BMC Gastroenterol; 2021 Feb; 21(1):58. PubMed ID: 33568105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Altered plasma levels of lysophospholipids in response to adrenalectomy of rats.
    Tsutsumi T; Ino M; Shimizu Y; Kawabata K; Nishi H; Tokumura A
    Prostaglandins Other Lipid Mediat; 2021 Oct; 156():106579. PubMed ID: 34245896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lysophosphatidylcholines modulate immunoregulatory checkpoints in peripheral monocytes and are associated with mortality in people with acute liver failure.
    Trovato FM; Zia R; Artru F; Mujib S; Jerome E; Cavazza A; Coen M; Wilson I; Holmes E; Morgan P; Singanayagam A; Bernsmeier C; Napoli S; Bernal W; Wendon J; Miquel R; Menon K; Patel VC; Smith J; Atkinson SR; Triantafyllou E; McPhail MJW
    J Hepatol; 2023 Mar; 78(3):558-573. PubMed ID: 36370949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extracellular and intracellular productions of lysophosphatidic acids and cyclic phosphatidic acids by lysophospholipase D from exogenously added lysophosphatidylcholines to cultured NRK52E cells.
    Tsutsumi T; Kawabata K; Yamazaki N; Tsukigawa K; Nishi H; Tokumura A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Sep; 1868(9):159349. PubMed ID: 37295607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polyunsaturated lysophosphatidic acid as a potential asthma biomarker.
    Ackerman SJ; Park GY; Christman JW; Nyenhuis S; Berdyshev E; Natarajan V
    Biomark Med; 2016; 10(2):123-35. PubMed ID: 26808693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presence of bioactive lysophosphatidic acid in renal effluent of rats with unilateral ureteral obstruction.
    Tsutsumi T; Adachi M; Nikawadori M; Morishige J; Tokumura A
    Life Sci; 2011 Aug; 89(5-6):195-203. PubMed ID: 21693124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.
    Magkrioti C; Oikonomou N; Kaffe E; Mouratis MA; Xylourgidis N; Barbayianni I; Megadoukas P; Harokopos V; Valavanis C; Chun J; Kosma A; Stathopoulos GT; Bouros E; Bouros D; Syrigos K; Aidinis V
    Cancer Res; 2018 Jul; 78(13):3634-3644. PubMed ID: 29724718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Laboratory-Based Clinical Research I am Aiming for].
    Yatomi Y
    Rinsho Byori; 2014 Nov; 62(11):1052-5. PubMed ID: 27509720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased aqueous autotaxin and lysophosphatidic acid levels are potential prognostic factors after trabeculectomy in different types of glaucoma.
    Igarashi N; Honjo M; Kurano M; Yatomi Y; Igarashi K; Kano K; Aoki J; Aihara M
    Sci Rep; 2018 Jul; 8(1):11304. PubMed ID: 30054520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Benzoxaboroles-Novel Autotaxin Inhibitors.
    Kraljić K; Jelić D; Žiher D; Cvrtila A; Dragojević S; Sinković V; Mesić M
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31547058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.
    Meng G; Tang X; Yang Z; Zhao Y; Curtis JM; McMullen TPW; Brindley DN
    FASEB J; 2019 Feb; 33(2):1899-1910. PubMed ID: 30192654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate.
    Song J; Clair T; Noh JH; Eun JW; Ryu SY; Lee SN; Ahn YM; Kim SY; Lee SH; Park WS; Yoo NJ; Lee JY; Nam SW
    Biochem Biophys Res Commun; 2005 Nov; 337(3):967-75. PubMed ID: 16219296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autotaxin overexpression causes embryonic lethality and vascular defects.
    Yukiura H; Kano K; Kise R; Inoue A; Aoki J
    PLoS One; 2015; 10(5):e0126734. PubMed ID: 25992708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of lysophosphatidic acid pathway modulators as therapies for fibrosis.
    Budd DC; Qian Y
    Future Med Chem; 2013 Oct; 5(16):1935-52. PubMed ID: 24175745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain.
    Ma L; Uchida H; Nagai J; Inoue M; Aoki J; Ueda H
    J Pharmacol Exp Ther; 2010 May; 333(2):540-6. PubMed ID: 20123931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimization of a pipemidic acid autotaxin inhibitor.
    Hoeglund AB; Bostic HE; Howard AL; Wanjala IW; Best MD; Baker DL; Parrill AL
    J Med Chem; 2010 Feb; 53(3):1056-66. PubMed ID: 20041668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.